Cargando…

Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study

BACKGROUND: There is growing evidence that misdiagnosis contributes to the high mortality rate in lung cancer patients complicated with pulmonary embolism (PE). This current study analyzed predictors of PE in lung cancer patients with lower extremity deep venous thrombosis (DVT) with the aim of pers...

Descripción completa

Detalles Bibliográficos
Autores principales: Dong, Hai-Yang, Tong, Min-Si, Wang, Juan, Liu, Yuan, Tao, Guang-Yu, Petersen, René Horsleben, Jara-Palomares, Luis, Wang, Yi, Sun, Yan-Bing, Chen, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: AME Publishing Company 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413029/
https://www.ncbi.nlm.nih.gov/pubmed/37577319
http://dx.doi.org/10.21037/tlcr-23-346
_version_ 1785087045693079552
author Dong, Hai-Yang
Tong, Min-Si
Wang, Juan
Liu, Yuan
Tao, Guang-Yu
Petersen, René Horsleben
Jara-Palomares, Luis
Wang, Yi
Sun, Yan-Bing
Chen, Jie
author_facet Dong, Hai-Yang
Tong, Min-Si
Wang, Juan
Liu, Yuan
Tao, Guang-Yu
Petersen, René Horsleben
Jara-Palomares, Luis
Wang, Yi
Sun, Yan-Bing
Chen, Jie
author_sort Dong, Hai-Yang
collection PubMed
description BACKGROUND: There is growing evidence that misdiagnosis contributes to the high mortality rate in lung cancer patients complicated with pulmonary embolism (PE). This current study analyzed predictors of PE in lung cancer patients with lower extremity deep venous thrombosis (DVT) with the aim of personalizing the treatment and management of patients with PE. METHODS: This retrospective case-control study included lung cancer patients with DVT at the emergency department of Shanghai Chest Hospital from January 2018 to December 2019. Patients were classified as having DVT with or without PE. The following characteristics were examined, including age, gender, smoking, hypertension, surgical trauma, hyperlipidemia, long-term bedridden status, calf swelling, coronary heart disease, chronic pulmonary disease, DVT location, DVT type, prothrombin time (PT), international normalized ratio (INR), activated partial thromboplastin time (APTT), thrombin time (TT), fibrinogen, and D-dimer, and univariate and multivariate analyses were performed. RESULTS: A total of 90 patients with lung cancer and DVT were analyzed, of whom 60% (54/90) had PE. Those variables independently associated to PE were hypertension [odds ratio (OR): 7.883, 95% confidence interval (CI): 2.038–30.495, P=0.003], long-term bedridden status (OR: 4.166, 95% CI: 1.236–14.044, P=0.021), and D-dimer levels (OR: 2.123, 95% CI: 1.476–3.053, P=0.000) were identified as independent risk factors for PE. The cut-off value of the receiver operating characteristic (ROC) curve for predicting PE by presented scoring system according to the risk factors was 1.5 and the area under the curve (AUC) was 0.84 (P<0.001). CONCLUSIONS: Hypertension, being bedridden for an extended period, and elevated serum D-dimer levels were independent risk factors of PE in lung cancer patients with lower extremity DVT. Novel strategies for patient management should be developed to decrease the risk of PE.
format Online
Article
Text
id pubmed-10413029
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher AME Publishing Company
record_format MEDLINE/PubMed
spelling pubmed-104130292023-08-11 Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study Dong, Hai-Yang Tong, Min-Si Wang, Juan Liu, Yuan Tao, Guang-Yu Petersen, René Horsleben Jara-Palomares, Luis Wang, Yi Sun, Yan-Bing Chen, Jie Transl Lung Cancer Res Original Article BACKGROUND: There is growing evidence that misdiagnosis contributes to the high mortality rate in lung cancer patients complicated with pulmonary embolism (PE). This current study analyzed predictors of PE in lung cancer patients with lower extremity deep venous thrombosis (DVT) with the aim of personalizing the treatment and management of patients with PE. METHODS: This retrospective case-control study included lung cancer patients with DVT at the emergency department of Shanghai Chest Hospital from January 2018 to December 2019. Patients were classified as having DVT with or without PE. The following characteristics were examined, including age, gender, smoking, hypertension, surgical trauma, hyperlipidemia, long-term bedridden status, calf swelling, coronary heart disease, chronic pulmonary disease, DVT location, DVT type, prothrombin time (PT), international normalized ratio (INR), activated partial thromboplastin time (APTT), thrombin time (TT), fibrinogen, and D-dimer, and univariate and multivariate analyses were performed. RESULTS: A total of 90 patients with lung cancer and DVT were analyzed, of whom 60% (54/90) had PE. Those variables independently associated to PE were hypertension [odds ratio (OR): 7.883, 95% confidence interval (CI): 2.038–30.495, P=0.003], long-term bedridden status (OR: 4.166, 95% CI: 1.236–14.044, P=0.021), and D-dimer levels (OR: 2.123, 95% CI: 1.476–3.053, P=0.000) were identified as independent risk factors for PE. The cut-off value of the receiver operating characteristic (ROC) curve for predicting PE by presented scoring system according to the risk factors was 1.5 and the area under the curve (AUC) was 0.84 (P<0.001). CONCLUSIONS: Hypertension, being bedridden for an extended period, and elevated serum D-dimer levels were independent risk factors of PE in lung cancer patients with lower extremity DVT. Novel strategies for patient management should be developed to decrease the risk of PE. AME Publishing Company 2023-07-19 2023-07-31 /pmc/articles/PMC10413029/ /pubmed/37577319 http://dx.doi.org/10.21037/tlcr-23-346 Text en 2023 Translational Lung Cancer Research. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) .
spellingShingle Original Article
Dong, Hai-Yang
Tong, Min-Si
Wang, Juan
Liu, Yuan
Tao, Guang-Yu
Petersen, René Horsleben
Jara-Palomares, Luis
Wang, Yi
Sun, Yan-Bing
Chen, Jie
Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study
title Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study
title_full Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study
title_fullStr Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study
title_full_unstemmed Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study
title_short Risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study
title_sort risk factors for pulmonary embolism in lung cancer patients with lower limb deep venous thrombosis: a case-control study
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10413029/
https://www.ncbi.nlm.nih.gov/pubmed/37577319
http://dx.doi.org/10.21037/tlcr-23-346
work_keys_str_mv AT donghaiyang riskfactorsforpulmonaryembolisminlungcancerpatientswithlowerlimbdeepvenousthrombosisacasecontrolstudy
AT tongminsi riskfactorsforpulmonaryembolisminlungcancerpatientswithlowerlimbdeepvenousthrombosisacasecontrolstudy
AT wangjuan riskfactorsforpulmonaryembolisminlungcancerpatientswithlowerlimbdeepvenousthrombosisacasecontrolstudy
AT liuyuan riskfactorsforpulmonaryembolisminlungcancerpatientswithlowerlimbdeepvenousthrombosisacasecontrolstudy
AT taoguangyu riskfactorsforpulmonaryembolisminlungcancerpatientswithlowerlimbdeepvenousthrombosisacasecontrolstudy
AT petersenrenehorsleben riskfactorsforpulmonaryembolisminlungcancerpatientswithlowerlimbdeepvenousthrombosisacasecontrolstudy
AT jarapalomaresluis riskfactorsforpulmonaryembolisminlungcancerpatientswithlowerlimbdeepvenousthrombosisacasecontrolstudy
AT wangyi riskfactorsforpulmonaryembolisminlungcancerpatientswithlowerlimbdeepvenousthrombosisacasecontrolstudy
AT sunyanbing riskfactorsforpulmonaryembolisminlungcancerpatientswithlowerlimbdeepvenousthrombosisacasecontrolstudy
AT chenjie riskfactorsforpulmonaryembolisminlungcancerpatientswithlowerlimbdeepvenousthrombosisacasecontrolstudy